Other

Asset acquisition

Over 2 years (FY 2023 to FY 2025), Asset acquisition shows a downward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025

How to read this metric

Higher values suggest significant investment in non-deductible assets, which can increase the effective tax rate.

Detailed definition

Represents the financial impact of acquiring assets, including intellectual property or technology, that are not deducti...

Peer comparison

Relevant for companies frequently acquiring IP or R&D assets through non-deductible structures.

Metric ID: other_effective_income_tax_rate_reconciliation_nondeduct_8c4cc4

Historical Data

3 years
 FY'23FY'24FY'25
Value$18.22M$0.00$0.00
YoY Change-100.0%
Range$0.00$18.22M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Insmed's asset acquisition?
Insmed (INSM) reported asset acquisition of $0.00 in Q4 2025.
What is the long-term trend for Insmed's asset acquisition?
Over 2 years (2023 to 2025), Insmed's asset acquisition has grown at a -100.0% compound annual growth rate (CAGR), from $18.22M to $0.00.
What does asset acquisition mean?
The financial impact of non-deductible costs associated with acquiring business assets.